000 | 01471 a2200433 4500 | ||
---|---|---|---|
005 | 20250513102904.0 | ||
264 | 0 | _c19970121 | |
008 | 199701s 0 0 eng d | ||
022 | _a0304-4602 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGunderson, L L | |
245 | 0 | 0 |
_aIndications for and results of irradiation +/- chemotherapy for rectal cancer. _h[electronic resource] |
260 |
_bAnnals of the Academy of Medicine, Singapore _cMay 1996 |
||
300 |
_a448-59 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHospitals, General |
650 | 0 | 4 | _aHospitals, Group Practice |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntraoperative Care |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMassachusetts |
650 | 0 | 4 | _aMinnesota |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPostoperative Care |
650 | 0 | 4 | _aPreoperative Care |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMartenson, J A | |
700 | 1 | _aHaddock, M G | |
773 | 0 |
_tAnnals of the Academy of Medicine, Singapore _gvol. 25 _gno. 3 _gp. 448-59 |
|
999 |
_c8869596 _d8869596 |